LifeStance Health Group Reaches Analyst Target Price
September 09, 2022 at 08:57 AM EDT
In recent trading, shares of LifeStance Health Group Inc (LFST) have crossed above the average analyst 12-month target price of $9.40, changing hands for $9.57/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..